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Abstract  
Thymic development of committed pro-T-cells from multipotent hematopoietic 
precursors offers a unique opportunity to dissect the molecular circuitry establishing 
cell identity in response to environmental signals.  This transition encompasses 
programmed shutoff of stem/progenitor genes, upregulation of T-cell specification 
genes, extensive proliferation, and commitment after a delay. We have incorporated 
these factors, as well as new single cell gene expression and developmental kinetics 
data, into a three-level dynamic model of commitment based upon regulation of the 
commitment gene Bcl11b. The first level is a core gene regulatory network 
architecture determined by transcription factor perturbation data, the second a 
stochastically controlled epigenetic gate, and the third a proliferation model validated 
by growth and commitment kinetics measured at single-cell levels.  Using expression 
values consistent with single molecule RNA-FISH measurements of key transcription 
factors, this single-cell model exhibits state switching consistent with measured 
population and clonal proliferation and commitment times. The resulting multi-scale 
model provides a powerful mechanistic framework for dissecting commitment 
dynamics. 
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INTRODUCTION  
Hematopoietic progenitors continually replenish the body's supply of blood cells 
including T lymphocytes. Many of the important regulatory factors controlling T-
lineage commitment are known (reviewed in1,2), as well as their patterns of 
expression3-5. Specific targets of several of these factors have been defined by 
perturbation studies, providing a strong basis for understanding the dynamic 
operation of an intrinsic gene regulatory network (GRN)6-26. However, the timing of 
observed transitions and evidence for a rate-limiting role of epigenetic constraints 
prevent modeling of the commitment process through a simple factor-target 
interaction approach. This paper presents a three-level model that integrates current 
understanding of this intrinsic GRN with insights into epigenetic control points and 
population dynamics characterizing T-cell commitment. 
Small numbers of multipotent hematopoietic precursors migrate continuously from 
bone marrow into the thymus27,28 where they enter the T-cell  developmental pathway, 
driven by Notch signalling and cytokines in the thymic microenvironment. These early 
progenitor cells are CD4 and CD8 double negative (DN), as well T-cell receptor 
negative. The Kithigh early thymic progenitors (ETP or DN1) proliferate before 
transitioning to DN2, a step marked by CD25 surface expression, then upregulate 
Bcl11b and undergo Bcl11b-dependent T-lineage commitment (Fig. 1A)13,14,24,29,30. 
Expression of the zinc finger transcription factor Bcl11b not only alters many aspects 
of genomic activity and cell function24,31,32, but also correlates with the functional 
committed state of single DN2 cells24 and can thus serve as a proxy for commitment. 
After Bcl11b activation Kithigh DN2a cells move through DN2b into the Kitlow DN3 stage, 
after which they can continue differentiation after rearranging a signalling competent 
T-cell receptor (Fig. 1A). A broad shift in expression of multiple regulatory genes 
occurs during commitment, and the stem/progenitor transcription factors expressed 
in DN1 and DN2 stages are generally extinguished (reviewed in1,33).  
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An important question is how the T-cell commitment decision is controlled. 
Computational modelling of GRNs represents an important approach for studying 
mechanisms controlling cell-fate decisions34. Here, we have developed a GRN model 
that incorporates the developmental period from thymic entry by multipotent 
progenitors to Bcl11b up-regulation and T-lineage commitment. Further, new 
experimental measurements have defined the relationship between proliferation 
timing and differentiative progression. These have enabled us to integrate this GRN 
model into a population-level model, as a framework for revealing new factors and 
roles for key known lineage commitment factors and to conduct dynamics analyses 
at both single cell and population levels for identifying transient states and general 
rules for cell differentiation.  
Earlier dynamical models dealt with the flux of T-cell progenitor populations through 
the DN1 to DN4 stages35 and the transcriptional network for Bcl11b activation 
assuming deterministic, direct transcriptional regulation by positive regulators Notch, 
GATA3, and TCF-136. Both models incorporated experimental evidence, but when 
juxtaposed, a contradiction emerged. The population model35 showed that primitive 
T-cell precursors transit from DN1 to DN2 after 7-10 cell divisions in vivo. Activation 
of Bcl11b takes place even later, 2-4 days after the cells become CD25+ DN2s in 
vitro24. However, all components of the transcriptional GRN model36 are expressed in 
the DN1 stage. A simple combination of previous models would predict Bcl11b to be 
turned on multiple cell cycles earlier than it is, well beyond the range of measurement 
error, suggesting that the deterministic assumption about Bcl11b control itself was 
incorrect or incomplete. 
Incorporating a separate, stochastic timing step downstream of a deterministic 
network could reconcile these features. In fact, recent evidence implies that the timing 
discrepancy reflects an intervening epigenetic event. Extensive repression marks and 
methylation are removed from the Bcl11b locus during its activation37,38, and the two 
alleles of Bcl11b within the same DN2 cell nucleus can become activated at different 
times, with discordances of up to 2+ days (and several cell cycles) despite exposure 
to the same transcription factors39. Consequently, in the model proposed here, an 
additional stochastic timing event for epigenetic activation has been interposed 
downstream of the action of the initial trans-acting regulators. This additional 
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stochastic step, governed by a new composite parameter, X, and opposed by positive 
inputs Runx1 and Notch, permits the model to mimic the observed biological time 
course while using realistic rate constants and parameter values for the regulatory 
factors that agree with measured values in single cells. 
Using these published data and our new experimental results, we propose a three-
stage dynamic model of early T-cell commitment. The gene network aspects of the 
model take into account the unique linkage of commitment to Bcl11b activation, and 
encompasses transcription and epigenetic levels of Bcl11b regulation to account for 
its proximal activation kinetics (Fig. 1). Step 1 is a single cell GRN model based on 
previously published perturbation experiments. Step 2 is an epigenetic model to 
account for local chromatin constraints limiting Bcl11b activation, even after trans-
factor requirements are met. The GRN model parameters were trained on new gene 
expression measurements from single molecule RNA-fluorescent in situ hybridization 
(smFISH). We have then embedded the two-step single-cell gene network model into 
a population model, trained with newly precise cell culture dynamics data, and 
validated by time-lapse imaging data of cultured DN1 clones.  The resulting multi-
scale model reveals mechanisms controlling early T-cell development and enables 
dissection of the kinetic controllers of commitment.     
 
RESULTS 
Experimental Results 
Proliferation and Development from DN1 (ETP) to Commitment 
Cells already within the DN2 stage, but still Bcl11b-nonexpressing, require ~2 days 
on average for Bcl11b activation24.  However, to relate the output of committed cells 
to events potentially occurring days earlier, we required new benchmark 
measurements of proliferation and development kinetics from DN1 to T-lineage 
commitment, and in particular the intervals between the DN1-DN2 transition and 
Bcl11b activation in individual clonal lineages. Bulk and clonal cultures were therefore 
analysed, starting with DN1 cells purified from thymi of Bcl11b-YFP reporter mice24 
(Fig. 2A). Sorted DN1s were stained with Cell Trace Violet (CTV) dye that tracks each 
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cell's proliferation history through dilution, and then co-cultured with Notch-ligand-
expressing OP9-DL1 stromal cells and growth-supporting cytokines, IL-7 and Flt3L, 
to promote T-lineage development. Parallel DN1 cultures were harvested after 2—5 
days and assessed by flow cytometry for total cell numbers, CTV-fluorescence 
intensity, the developmentally-regulated surface marker, CD25 (marking transition to 
DN2), and Bcl11b-YFP (Fig. 2B). The number of divisions each cell had experienced 
was determined by flow cytometric measurement of residual CTV staining as 
calibrated in control cultures (Fig. S1).  Numbers of cell divisions experienced by 
individual cells are represented as different colours in flow cytometry plots (Fig. 2B) 
and as population distributions of cells with different numbers of cell divisions at each 
time (Fig. 2C). 
Approximately 50% of DN1 cells turned on CD25 by day 2 of culture, with increasing 
percentages over time (Fig. 2B,D). However, few Bcl11b-YFP+ cells appeared among 
the CD25+ cells until day 3, with percentages of YFP+CD25+ cells then increasing over 
time (Fig. 2B,D). CTV analysis at day 2 showed that cell division was not required for 
CD25 expression (red dots=cells with 0 divisions), and that the most rapidly dividing 
cells were neither most or least likely to turn on CD25. By days 4-5, CD25+ cells had 
divided more rapidly than cells remaining CD25-, as seen by the shift towards a larger 
population with the lowest CTV levels (turquoise or lilac) (Fig. 2B). Bcl11b-YFP was 
not expressed in non-proliferating cells, and Bcl11b-YFP+ cells appeared to have 
proliferated more rapidly than cells remaining Bcl11b-YFP- by days 4 and 5, since 
YFP+ cells generally retained lower CTV levels (Fig. 2B).  Overall, these results confirm 
that CD25 is expressed before Bcl11b-YFP (Fig. 2B,D) and that CD25 can be turned 
on without cell division, while Bcl11b-YFP cannot. Furthermore, more 
developmentally advanced cells in these cultures proliferated somewhat faster than 
those that were delayed. 
Clonal Kinetic Analysis of Differentiation from DN1 
Because DN1s divide at different rates, the output populations become dominated 
over time by progeny of the most rapidly proliferating input cells. To resolve at a clonal 
level whether Bcl11b expression depends on time or cell cycles, individual thymic 
DN1 cells were co-cultured with OP9-DL1 stroma in microwells and microscopically 
imaged over time24 (Fig. 3A). DN1s were purified from thymi of mice with a 
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constitutively-expressed membrane-(m)Tomato transgene, for cell segmentation and 
counts, as well as the nuclear Bcl11b-YFP reporter, and plated into microwells pre-
seeded with OP9-DL1 cells. Microwells verified to start with single live DN1 cells were 
imaged daily for 6-7 days to determine clonal expansion and onsets of surface CD25 
and nuclear Bcl11b-YFP expression within individual clones. Merged false-colour 
images of microwells in mTomato, CD25-AlexaFluor647, and Bcl11b-YFP 
fluorescence channels over time, are shown in Fig. 3B from one representative clone 
of 64 clones imaged. Two of the 64 DN1 clones generated only non-T cell lineage 
cells, possibly granulocytes, but the remainder turned on CD25 and most turned on 
Bcl11b-YFP within 7 days (Fig. S2). Fluorescence thresholds for determining CD25 
and Bcl11b-YFP positivity were calculated using background fluorescence estimates 
(Fig. S3). Higher magnification images for cells from two representative clones from 
days 1-6 (Fig. 3C) show that at day 1 only the segmentation marker mTomato (grey) 
was expressed.  In these clones, surface CD25 (magenta) was turned on by day 2 or 
3 (wells 23 and 41 respectively), about 2 days before nuclear Bcl11b-YFP-positive 
cells (cyan) appeared by day 4 or 5. 
Differentiation dynamics for all imaged wells combined are shown in Fig. 3D. Most 
individual clones achieved similar proliferation rates but began with different lag times 
(Fig. 3E), reflecting heterogeneity within the starting DN1 population. At early 
timepoints, cells that remained DN1 had proliferated less than the CD25+ DN2s (Fig. 
S4), in agreement with CTV data. There was wide variability in the timing of CD25 and 
Bcl11b-YFP expression between clones (Figs. 3F, S2).  CD25 came on most 
frequently on days 1-2 (76%) although 16% of clones did not turn on CD25 until >4-
5 days of culture, while times to the onset of Bcl11b-YFP expression ranged from 3—
7 days. CD25 up-regulation was not synchronous within some clones, hinting at a 
stochastic element even in the transition to DN2.  
To test the determinism of commitment programming, we asked whether cells are 
programmed to turn on Bcl11b after a fixed period of time or fixed number of cell 
cycles after making the DN1-DN2 transition. Fig. 3F shows the differences for each 
clone between the times when >50% of cells were scored as CD25+ and as Bcl11b-
YFP+, in elapsed time and in cell cycles (Fig. 3F). In fact, the intervals between entering 
the DN2 state (CD25+) and commitment (Bcl11b-YFP+) were highly variable both in 
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absolute times and in cell cycles, taking from <1 to >5 days and from 1 to 7 cell 
divisions.  Furthermore, Bcl11b-YFP was not turned on synchronously within a clone, 
generally requiring 2-3 days from expression in the first cells to expression in 100% 
of the cells (Figs. 3C (well 23, day 4), S2). Thus, daughter cells from individual DN1 
cells are not only heterogeneous in their clonal founders’ differentiation states, but 
also show a large stochastic element in timing of Bcl11b up-regulation after entering 
the DN2 state39. 
Single Cell RNA-FISH Measurement of Key Transcription Factors 
Potential drivers of commitment include TCF1 (Tcf7), Gata3, and Runx1, which are 
necessary positive inputs for Bcl11b expression24, while PU.1 (Spi1) antagonizes 
developmental progression through commitment23,40. To determine the normal ranges 
of expression of Spi1, Tcf7, Runx1 and Gata3 in individual T-cell precursors in 
developmental stages leading up to Bcl11b activation for the model, DN thymocytes 
were purified from 5-week-old mice and analysed by multiplex single molecule RNA-
FISH (smFISH) (Fig. 4A,B). Developmental stages of individual cells were scored 
based on measured Kit, CD25 protein and mRNA levels. Absolute transcript counts 
showed that Runx1, Gata3, and Tcf7 expression was variable in DN1s, increasing up 
to 2x in DN2s (DN2 median transcript levels/cell: Tcf7»40; Runx1»12; Gata3»8) (Fig. 
4C). In contrast, Spi1 was highest in DN1 and DN2, and declined with further 
development, in accord with previous bulk population measurements. Bcl11b was not 
expressed in DN1s but turned on in CD25+ DN2s (median transcripts/cell»15), 
remaining high into DN3 (Fig. 4C). 
These gene expression changes from DN1 to DN2 were used as input to the GRN 
model as an approximation for developmental changes in transcription factor protein. 
The half-lives of these proteins can differ substantially; for example, PU.1 has a half-
life at least 10x that of TCF1, Runx1, and Gata336,41, and so we used their relative 
expression patterns, rather than absolute protein levels.   
Modelling Results 
As described earlier, a GRN model for Bcl11b activation during commitment should 
incorporate three separate aspects of control. First, four positive regulatory inputs, 
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Notch signaling, TCF1, Gata3, and Runx1, are needed in the DN1-DN2a stages to 
make Bcl11b eligible for activation.  Second, TCF1 and GATA3 work in a hit-and-run 
way and are dispensable for the final steps of Bcl11b induction, but Runx1 and Notch 
act through DN2a stage24. Third, activation of each Bcl11b allele, in a cell that has 
already fulfilled eligibility requirements, still requires a slow stochastic epigenetic 
remodelling process39. To accommodate these requirements, we separated an initial, 
deterministic process from a subsequent, stochastic process (Fig. 1B).  
 
Thus, we developed a three-level dynamic model. (1) In the  deterministic level, 
network dynamics between Notch signalling, Runx1, Tcf7, Gata3, and the 
antagonistic regulator PU.1 determine cell permissiveness for Bcl11b activation, via 
effects on the constraint function X. (2) In the stochastic level, the transition of Bcl11b 
from closed to open state is influenced by the inhibitory function, X, balanced against 
the continuing positive drivers Runx1 and Notch signalling. (3) In the population level, 
these single-cell processes are combined with a dynamic population growth model 
that accounts for the expansion of cells that have and have not yet activated Bcl11b. 
While the marker CD25 plays an important role in interpreting the experimental results 
relative to the DN1-DN2 transition, it is not a regulator and therefore is not explicitly 
included in these models. Model development and validation procedures are shown 
in Fig. 5. 
 
The Gene Regulatory Network Architecture 
For the first level of the single cell model we proposed a GRN architecture based upon 
gene expression, perturbation experiments and literature (Table 1), describing the 
interplay between the T-cell commitment genes Tcf7, Gata3, Runx1 and the opposing 
gene Spi1 (Fig. 6A). Rather than having these regulators controlling Bcl11b 
transcription directly, we proposed that their inputs collectively removed the 
obstruction from an antagonist of Bcl11b opening, X, representing a composite of the 
slow chromatin opening mechanism and the actions of any additional DN1-specific 
antagonists of Bcl11b expression, still to be defined. Only X, Notch signalling, and 
Runx1 then propagate to the next, stochastic level.  
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Parameter Setting Based on Pseudo-Time-Series 
From the single cell FISH data (Fig. 4), we created pseudo-time-series from DN1 
through DN2, which show that in early DN1 expression of Tcf7 increases substantially 
and becomes predominant (Fig. 6B). After a delay (200 arbitrary time units), Bcl11b 
transcription begins. Furthermore, Gata3 expression slightly rises with increasing Tcf7 
expression, along with Runx1. Expression of the opposing gene PU.1 is fairly constant 
at a low level through these stages, turning off later. The GRN model parameters 
(Table S1) were optimised from these pseudo-time-series (Fig. S5). 
Transcriptional Level - Deterministic Simulations 
We developed the computational model for the step 1 GRN (Fig. 6A) with Shea-Ackers 
deterministic rate equations42 (Methods). Deterministic simulation results from the 
model (with initial conditions for Tcf7, Gata3, PU.1 and Runx1 equal to the first 
pseudo-time-series expression values and the X function initially highly active) show 
that the system, when exposed to external Notch signalling, moves towards a steady 
state where the T-cell factors are highly expressed, with a pronounced increase in 
Tcf7, while PU.1 and X activity levels descend towards low values.  
Transcriptional Level - Stochastic Simulations 
Stochastic simulations43 of the GRN model (Fig. 7A) in individual cells with the same 
parameters (Table S1) show that noise could be a source of heterogeneity in DN1 
cells, as not all simulations exhibited dynamic switching towards a steady state with 
high T-cell factors (Fig. 7C). Moreover, the stochastic simulations showed that GRN 
intrinsic noise sometimes leads to delays of the switch towards T-cell commitment. 
Epigenetic Level 
The second level of modelling consists of a simplified epigenetic model for the Bcl11b 
regulatory region with two possible states, open or closed, to account for the 
stochastic all-or-none activation timing observed for individual Bcl11b alleles (Fig. 
8B). While the roles for Tcf7 and Gata3 apparently become dispensable immediately 
before Bcl11b activation, positive influences from Notch signalling and Runx1 remain. 
Notch signalling augments the likelihood of activation per unit time24, while Runx1 
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positively modulates expression levels24,39. Therefore, our model places these 
regulators in opposition to function X (Fig. 8A,B).   
To account for the slow and potentially processive nature of this epigenetic transition, 
we used a model developed for calculating epigenetic activation as a function of the 
number of open (unmethylated) and closed (methylated) CpG dinucleotides at 
functional regulatory regions44 (Methods). Here it could apply to other probabilistic 
local chromatin states as well as DNA methylation. Notch signalling and Runx1 levels 
obtained from stochastic GRN simulations serve as positive regulators for the 
probabilities that CpG sites (or equivalent chromatin features that are propagated by 
similar chromatin “reader-writer” mechanisms) become open while X activity levels 
link to the probability of Bcl11b CpGs remaining closed. 
Merging Transcriptional with Epigenetic Levels 
We next conducted stochastic simulations of the single cell multi-level model 
incorporating Bcl11b regulatory region state dynamics predicting that early T-cell 
progenitor cells are heterogeneous in their CpG methylation states37 or equivalent 
open/closed chromatin states in the Bcl11b regulatory regions. The simulations 
showed that the Bcl11b locus can remain closed or become opened depending on 
the status of these CpG (or equivalent) sites, as dictated by Notch signalling, Runx1 
expression, and opposing X activity (Fig. 7D). The stochastic treatment of the 
epigenetic level predicits further delays in T-cell commitment. In an example when the 
switch is thrown by day 3 (i.e., Tcf7 and Gata3 becoming highly expressed while X 
activity drops), the corresponding stochastic simulation of Bcl11b status showed that 
the regulatory system only opens after day 4 (Fig. 7C, lower panels). 
Based on three sets of 100 stochastic simulations of this multi-level model, the model 
predicted that on days 2 and 3 <20% of cells would express Bcl11b, ~40% on day 4, 
and ~50% on day 5. These predictions agree well with direct monitoring of Bcl11b-
YFP during 5 days in DN1-derived populations going through commitment (Fig. 2D, 
3D). The distributions of cell percentages with low  X-levels (Fig. 7F) are very similar 
to the distributions of CD25-positive cells (Fig. 2D, 3D), suggesting that loss of X 
activity might be correlated to CD25 expression, consistent with the observation that 
Bcl11b expression follows CD25 upregulation. Thus, the two-level single cell model 
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shows that stochastic mechanisms controlling eligibility for chromatin opening 
downstream of the core deterministic GRN can account for the observed delays in T-
cell progenitor commitment. 
Furthermore, the model predicts the effects of knocking down Tcf7, Gata3 and Runx1, 
which typically reach 15-25% of their original expression in RNA interference 
experiments. This corresponds to few molecular copies, thus requiring stochastic 
simulations.  Early knock-down of Tcf7, Gata3 or Runx1 halts progression towards a 
state of high T-cell factors and low PU.1.  Instead, the system results in a steady state 
with high PU.1 and low Tcf7, Gata3 and Runx1, keeping the Bcl11b locus closed (Fig. 
S6). In contrast, simulating the Tcf7 or Gata3 knock-down in DN2, after X is 
inactivated, showed no continued requirement for Tcf7 or Gata3 (Fig. S7), consistent 
with experimental findings24. 
 
Population Model 
To capture population dynamics, we developed population models based upon CTV 
data. We first tested the hypothesis that cell cycle length is independent of generation, 
which was clearly incorrect (Supplementary Material). We then relaxed this 
assumption, with each cell having its division time stochastically determined from a 
normal distribution with mean and variance depending upon cell generation (Fig. 8A). 
Normalised cell number distributions among different generations within simulated 
cell cultures up to day 5 were compared to the CTV data (Fig. 3C), allowing us to 
determine the cell cycle distribution parameters (Table S3). We monitored each cell 
generation, and calculated the proportion of cells in each generation at each day from 
172 simulations (Fig. 8B) with resulting distributions very similar to experimental data 
(Fig. 3C).  
Full Multi-scale Model 
We next implemented the single-cell GRN model within the multi-cell simulation 
environment to determine how cell proliferation affects population distributions of T-
cell fate-committed versus non-committed cells. To take into account the impact of 
cell division on the Bcl11b locus epigenetic state, we used an advanced version of 
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the epigenetic model with an intermediate state between open and closed (Methods). 
Notably, the optimal number of “CpG equivalent” units that needed to be de-
repressed was found to be 500, consistent with the very extended potential regulatory 
regions associated with the Bcl11b gene32,37.  
We computed the proportion of cells for which the Bcl11b regulatory region was in 
the open state in 172 simulations starting with one cell proliferating for five days. The 
model predicts that none of the cells have the Bcl11b regulatory region open at day 
2, while at day 3 roughly 8% are open. The proportion then increases to 47% at day 
4 and 60% at day 5 (Fig. 8C). We also computed the percentage of cells that lose X 
activity at time points corresponding to each day (Fig. 8C). Our multi-scale model 
predicts that X activity is lost in ~50% of the cells by day 2, and the proportion lacking 
X gradually increases, reaching >70% by day 5. This proportion of cells predicted to 
have lost X activity (Fig. 8C), interestingly, is close to the proportion of CD25-positive 
cells from experiments (Figs. 2D, 3D). Model predictions regarding the proportions of 
cells that lost X activity and then activated Bcl11b agree well with results from 
monitoring CD25 and Bcl11b-YFP expression in the developmental kinetics 
experiments (Fig. 2D, 3D). 
Finally, the multi-scale model predictions were validated by imaging results from the 
62 T-lineage DN1 clones (Fig. 3), corresponding to our model simulations starting with 
single clones and including cell divisions, GRN states and Bcl11b epigenetic 
dynamics. The single cell imaging experiments agree well with our model predictions 
that ~50% of the clones contained >50% CD25+ cells at day 2 while almost none of 
the cells were yet Bcl11b-YFP-positive (Fig. 3D). The proportions of clones with >50% 
CD25+ and >50% Bcl11b+ cells then increased gradually, reaching more than 70% of 
clones by day 5 (Fig. 3D). 
The multi-scale model also predicted the variability in proliferation kinetics between 
simulated single cell clones (Fig. 8D). The 'in silico' cell numbers were in good 
agreement with the observed ones (Fig. 3E). Furthermore, model predictions showed 
that the clones would not be fully synchronised, with 10/172 in silico “clones” 
producing 50% of Bcl11b+ cells as early as day 3, with others waiting until day 4, 5 or 
even later (Fig. 8E). Similar results are obtained from monitoring the proportion of 
clones reaching 50% of cells without X activity (i.e., 95 of the simulated clones lost X 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/667709doi: bioRxiv preprint first posted online Jun. 11, 2019; 
13 
 
activity at day 2 while 13 turned off X activity at day 5) (Fig. 8F). This agrees well with 
analysis for cultured and imaged DN1 clones, with variable timing for expression of 
both CD25 and Bcl11b (Fig. 3F). Thus, the predicted DN1 clonal heterogeneity in 
differentiation was validated by experimental data. 
 
DISCUSSION 
We have developed, explored and validated an integrated computational multi-scale 
model for early T-cell development and commitment kinetics. Commitment of 
multipotent precursors to the T-cell fate is particularly accessible for modelling 
because, at the single-cell level, commitment corresponds to Bcl11b activation. Thus, 
the model explains commitment kinetics in terms of the gene network circuitry 
controlling Bcl11b expression by incorporating results from both single cell and 
population-level experiments elucidating the process on different scales. After a 
deterministic first level, our model is stochastic at the second level, including an 
epigenetic part to predict chromatin opening. Finally, the gene control model is 
integrated with a cell population model to align cell model properties with measured 
population behaviour. 
Whereas other hematopoietic stem cell commitment processes have been subject to 
mathematical model investigations34, few attempts have been made for early T-
cells36,45. Importantly, our model incorporates the complex molecular mechanisms 
shown recently to be involved in Bcl11b activation including the four known positive 
regulators contributing to the logic of Bcl11b activation, and the additional, slow 
epigenetic step that creates a stochastic delay in Bcl11b activation, long after the 
positive regulators are present. This level of control is probably not unique to Bcl11b 
regulation but has been demonstrated in particular depth for developmental activation 
of this gene39.  
Computational models for epigenetics and GRNs were proposed in the context of 
pluripotency acquisition through cell reprogramming44,46. Multi-scale modelling 
approaches, unifying observations from the intra-cellular to cell population scale, have 
also been used to model heterogeneity and function of mature peripheral T-cells, 
reviewed in47. This is, to our knowledge, the first time a computational model, which 
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considers the epigenetic and genetic levels of regulation, is used to explain and 
predict dynamics of T-cell lineage commitment.  
The choice to use continuous-valued rather than Boolean transcriptional models has 
the advantage of avoiding discretising the data in instances when experimental real-
valued gene expression levels are relevant for the problem studied, as in this case. 
On the other hand, with a Boolean approach one can probe larger networks than that 
modeled here. These issues have been briefly reviewed34. We have chosen the 
continuous-valued approach as our current data provide information beyond on/off 
representations, and previous investigations of important regulators of Bcl11b enable 
us to focus on a few key genes. 
The design of the stochastic epigenetic level of the network was novel, incorporating 
some features not usually included in GRNs, in order to encompass the known 
mechanisms involved.  Published experimental measurements indicate that a default 
repressive chromatin state is probably a major contributor to the stochastic timing of 
activation, with a delay from the activation of one allele to the other - a measure of 
noise in time to relieve an epigenetic barrier - on the order of days39. We linked relief 
of this negative epigenetic function (X) to the observed developmental timing control, 
because Bcl11b is only turned on in the DN2a stage, never (or rarely) in DN1, even 
though all the known positive regulators are already present in DN1.  For parsimony, 
we have proposed an architecture in which the positive regulators in the first 
deterministic layer of the model work toward down-regulating X, leaving the second 
stochastic layer to determine when Bcl11b will respond by activation. 
Importantly, X is a composite function in this model, not a single undefined regulatory 
gene. As Bcl11b starts out in an epigenetically silent state inherited from 
hematopoietic stem cells, X measures the resistance to the opening of relevant cis-
regulatory elements at each allele of the locus. It is possible that some transcription 
factors inherited from stem/multipotent progenitors and still active in DN1 could 
sustain X, but this epigenetic constraint itself cannot be equated with a trans-acting 
repressor. Therefore, in the stochastic level of the model, we have taken the balance 
of Notch signals and Runx1 against decreasing X to drive a stepwise epigenetic 
opening process that we have modelled analogously to the removal of methylated 
CpGs. While demethylation may be part of this process, the use of this formalism is 
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more abstract here and indicates the stochastic but neighbour-biased and 
progressive nature that is shared by demethylation with other epigenetic opening 
processes. 
Stochastic simulations of the GRN controlling the first steps in T-cell commitment 
show that the switch towards a state with low X-levels does not occur in a 
synchronised manner between model simulations with identical initial conditions.  This 
suggests that GRN intrinsic noise could be a source of heterogeneity in the loss of X, 
which is one of the first steps in the T-cell commitment process and we speculate that 
it could be linked to the DN1 to DN2 transition marked by CD25 expression. 
CD25 expression, the key marker of transition to DN2, was monitored in experiments 
but not included in the model. Nevertheless it provides several key insights into 
Bcl11b expression kinetics.  First, the timing of CD25 expression is quite 
heterogeneous in different DN1 clones, confirming DN1 cell heterogeneity1,35. 
Furthermore, the clonal analysis shows that CD25+ DN2 cells divide more quickly than 
CD25- DN1s. One ramification of more rapid cell division is the dilution of proteins 
affecting the potential speed of epigenetic changes48. Finally, both CTV and clonal 
imaging confirm that Bcl11b is typically turned on days and many cell cycles after 
CD25, in every clone (Fig. 2,3). This is surprisingly comparable to the average and 
range of delays predicted between X function down-regulation and Bcl11b opening 
in the model, hinting at possible common regulatory elements yet to be determined.   
In summary, this new model that integrates three distinct types of mechanistic control 
provides a quantitative understanding of commitment kinetics in early T cell 
precursors, and a valuable in silico tool to help discover new commitment regulators 
in this system. 
 
METHODS  
Mice 
C57Bl/6, B6.Bcl11byfp/yfp (Bcl11btm1.1Evr) reporter mice24, and B6.129(Cg)-
Gt(ROSA)26Sor{tm4(ACTB-tdTomato,-EGFP) mice expressing ubiquitous membrane Tomato 
(Jackson Laboratory) were bred and maintained in the Caltech Lab Animal Resources 
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Facility in accordance with protocols reviewed and approved by the Animal Care and 
Use Committee at California Institute of Technology. Note that the Bcl11byfp allele is 
a nondisruptive insertion of an internal ribosome entry site (IRES)-mCitrine (YFP) 
reporter into the 3’ untranslated region of the last Bcl11b exon, which allows fully 
normal expression of the Bcl11b protein from the same allele. 
DN cell purification 
Single cell suspensions were made from thymuses from 4-6-week-old mice. 
Thymuses were removed, passed through sterile metal meshes and collected in 1X 
Hanks Balanced Salt Solution supplemented with 0.5 % fraction V bovine serum 
albumin, 10mM Hepes buffer (Gibco), 5mM MgCl2, and DNAseI. After pelleting, the 
cells were resuspended in a cocktail of biotinylated antibodies to deplete unwanted 
cells: CD8a (53-6.7), TCRgd (GL3), TCRb (572597), Gr1 (R86.8C5), Ter119 (Ter119), 
NK1.1 (PK136), CD11b, and CD11c (N418), after which the cells were incubated with 
streptavidin-coated magnetic beads and then passed through a magnetic column 
(Miltenyi Biotec). The eluted DN cells were either used directly for RNA-FISH analysis 
or further purified by staining with fluorescent antibodies to CD44, Kit, CD25 and then 
sorting on a BD Biosciences FACSAria or FACSAriaFusion or a Sony SY3200 Cell 
Sorter in the Caltech Flow Cytometry Facility. For bulk cultures or clonal imaging DN1 
cells were sorted as CD44high Kithigh CD25-negative Bcl11b-YFP-negative cells. Note 
that for simplicity, throughout this paper, we use "DN1" to refer to the Kithigh subset of 
CD44+ CD25- cells that contains the T-cell precursor function, also known as ETP. 
Single Molecule Multiplex Fluorescent in situ Hybridization (sm-FISH) 
Probe design and synthesis 
The gene-specific primary probes for each gene tested were designed as previously 
described{Shah, 2016 #2362}, with some modifications: each probe comprised a 
mRNA-complementary 35-mer sequence plus a shorter “gene handle” sequence that 
was shared by all probes against the same gene. All probes were blasted against the 
mouse transcriptome and expected copy numbers of off-target probe hits were 
calculated using predicted RNA counts in the ENCODE database for murine 
thymocytes. BLAST hits on any sequences other than the target gene with a 15-nt 
match were considered off-target hits. Any probe that hit an expected total off-target 
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copy number exceeding 500 in count table was dropped. Probes were sequentially 
dropped from genes until any off-target gene was hit by no more than 6 probes from 
the entire pool. At this stage, all of the viable candidate probes for each gene had 
been identified. For the final probe set, the best possible subset from the viable 
probes for each gene was selected such that none of the final probes used were within 
2-nt bases of each other on the target mRNA sequence, with no-overlapping 
hybridization regions and GC-content close to 55%. Primary probes were synthesised 
and amplified from array-synthesised oligo-pool as previously described49. The 
readout oligos against specific gene handles on primary probes were ordered from 
IDT (Integrated DNA Technologies, Coralville, Iowa) with 5’-amino modification and 
were coupled with NHS (N-hydroxysuccinimide)-ester labelled fluorescent dyes 
(Alexa 488, 594, 647 (Thermo Fisher Scientific) and Cy3B (GE Healthcare)) and purified 
through HPLC. 
smFISH experiment and image acquisition 
First, the isolated cells were spun onto an aminosilane modified coverslip, crosslinked 
with 4 % Formaldehyde (ThermoScientific 28908) in 1X PBS for 10min, and 
permeabilized in 70 % EtOH overnight at 4C. Samples were imaged first to record the 
surface antibody signals, followed by briefly bleaching away antibody signals through 
incubation in 0.1 % NaBH4 (Sigma 452882) in 1XPBS for 10 min. Then, the samples 
were 1) hybridised overnight at 37° C with primary mRNA probes at 1 nM each oligo 
concentration in 50% Hybridization Buffer (50% HB: 2X SSC (saline sodium citrate, 
Invitrogen 15557-036), 50% (v/v) Formamide (Ambion AM9344), 10 % Dextran Sulfate 
(Sigma D8906) in Ultrapure water (Invitrogen 10977-015)); then 2) washed in 50 % 
Wash Buffer [2X SSC, 50 % (v/v) Formamide, 0.1 % Triton-X 100 (Sigma X-100)] for 
20 minutes, followed by incubation in 2X SSC for 10 minutes. The samples were then 
3) incubated with fluorophore-coupled readout oligos, in 30 % Hybridization buffer 
(30% HB: 2X SSC, 30% (v/v) Formaldehyde, 10% Dextran Sulfate in Ultrapure water) 
at concentrations of 10 nM each oligonucleotide for 30 minutes; this was followed by 
4) 5 minutes wash in 30 % Wash Buffer (2X SSC, 30 % Formamide (v/v), 0.1 % Triton-
X 100 (Sigma X-100)), 3 minute wash in 2X SSC and DAPI staining. We then 5) 
proceeded to imaging of this round of hybridization as described below. After image 
acquisition, 6) the samples were incubated with 70% formamide with 1x PBS at room 
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temperature for 30 minutes, followed by 3 rounds of washing in 1x PBS for 5 minutes 
each round. The procedures 3)-6) were then repeated with a set of gene-specific 
readout oligos until the completion of measurements of all genes of interest, as 
illustrated in Fig. 4A. 
Samples were imaged in an anti-bleaching buffer (20 mM Tris-HCl, 50 mM NaCl, 0.8 
% glucose, saturated Trolox (Acros Organics 218940050), pyranose oxidase (OD405 
= 0.05) (Sigma P4234), and catalase at a dilution of 1/1000 (Sigma C3155)) with the 
microscope (Olympus IX81) equipped with a confocal scanner unit (Yokogawa CSU-
W1), a CCD camera (Andor iKon-M 934), 100x oil objective lens (Olympus NA 1.4), 
and a motorised stage (ASI MS2000). Lasers from CNI and filter sets from Semrock 
were used. Snapshots were acquired with 0.5 µm z steps for more than 10 positions 
per sample. 
The cells were segmented and categorised according to surface antibodies, and dots 
representing individual mRNA molecules were assigned to individual cells as shown 
in Fig. 4B. 
Bulk cell cultures 
For experiments on developmental kinetics DN1 cells were cultured on OP9-DL1 
stromal cells as previously described24,29 in aMEM medium supplemented with L-
glutamine, penicillin, streptomycin (OP9 culture medium) and IL-7 (5 ng/ml) and Flt3L 
(10 ng/ml).  For tracking proliferation in bulk cultures, FACS purified DN1 cells were 
stained in 5 µM Cell Trace Violet (Molecular Probes) for 7 minutes at 37oC in HBSS 
and washed 2X with whole medium before being plated in 96-well OP9-DL1 co-
cultures.  Cells were incubated at 37oC 7% CO2, harvested on days 2, 3, 4, and 5 by 
vigorous pipetting, and evaluated for developmental status by staining with 
antibodies, CD25 and Kit for development and CD45 to separate developing cells 
from stroma, plus a viability dye, 7AAD.  The cells were then analysed for expression 
of these markers plus Bcl11b-YFP using a Miltenyi MACSQUANT flow cytometer.  
Analysis was carried out using FlowJo software (Treestar).  CTV measurements of cell 
division histories were calibrated using total DN (DN1—4) cultures on OP9-DL1 
stroma (Fig. S1). 
Clonal Image Analysis 
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To follow the kinetics of development and proliferation in individual DN1-derived 
clones by microscopic imaging, several technical problems had to be solved.  First, 
to allow for accurate identification and segmentation of developing cells of varying 
shapes and sizes on a background layer of OP9-DL1 stroma, we needed to use cells 
purified from B6.R26mmTom/mTom Bcl11byfp/yfp J mice expressing ubiquitous membrane 
Tomato (Jackson Laboratory).  We then crossed and backcrossed this strain to our 
B6.Bcl11byfp/yfp reporter mice 24 until both loci were homozygous (B6.ROSA26-
mTom;Bcl11b-YFP mice). To enable the use of the Bcl11b-YFP reporter for imaging 
the commitment status of individual developing T-cell precursors, GFP had to be 
removed from the original OP9-DL1 stromal cells50.  To do this, we designed guide 
RNAs targeting GFP and electroporated them along with a CRISPR puromycin 
plasmid v2.0 (Plasmid # 62988, Addgene) into OP9-DL1-GFP cells using the Lonza 
Nucleofector Kit.  After puromycin selection, different clones were analysed for GFP 
expression and one clone found to be completely negative for GFP (OP9-DL1-
delGFP1) which was selected for use in imaging. 
Developing T-cells are extremely active in motility, so individual DN1 cells had to be 
confined in wells for imaging.  We used a protocol similar to our previous experiments 
with DN2 cells 24, but we found that the background of the clear wells was too high in 
the fluorescence channels used in these experiments, so black microwells were 
substituted.  Black 8mm circular poly (dimethyl siloxane) PDMS micromeshes with 
over 150 microwells punched/micromesh, each approximately 250 µM wide X 100 µM 
deep, were custom fabricated by Microsurfaces (Australia).  One day before the start 
of co-culture and imaging these micro meshes were adhered to 2-4 (macro)wells of a 
24-well glass-bottom plate (P24G-1.0-13-F) (MatTek, Ashland, CA), sterilized with 
ethanol, and washed in accordance with manufacturer’s instructions, and then 
seeded with 5,000 OP9-DL1-delGFP stromal cells. Cultures were carried out in OP9 
culture medium prepared as previously described except for the omission of pH 
indicator, phenol red, from the medium, which gives background fluorescence, and 
with the addition of 10mM Hepes buffer to stabilize the pH of the wells during imaging. 
On the first day of culture the following were added to the medium: 10 ng/ml Flt3L, 5 
ng/ml IL-7, and 0.05 µg/ml anti-CD25-AlexaFluor647 antibody (BioLegend) for 
detection of CD25 surface expression.  DN cells were isolated from B6.ROSA26-
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mTom/Bcl11b-YFP mice and DN1 cells were FACS-purified as described above. 
1,500 sorted DN1 cells were added to each well of the 24-well plate which had the 
microwells pre-seeded with OP9-DL1-delGFP.  The cells were allowed to recover for 
at least one-hour at 37C, 7% CO2, before transfer to the Leica 6000 wide-field 
fluorescence microscope with Metamorph software and an incubation chamber pre-
set to 37C, 7 % CO2.  Each microwell was briefly checked using the 40X objective, 
which allowed imaging of one entire microwell, for mTomato-positive cells.  
Microwells with 1 or 2 cells had their X-Y stage positions marked.  All marked 
microwells were imaged daily using differential interference contrast (DIC) and three 
fluorescence channels: 504 excitation-542 filter for YFP, 560-607 for mTomato, and 
650-684 for CD25-AlexaFluor647.  Wells found to have one mTomato positive cell on 
either day 1 or 2 and cells present throughout the culture period were selected to 
further analysis.  mTomato-positive cells were segmented and analysed using Fiji 
(ImageJ) and by hand to obtain cell area and CD25 and Bcl11b-YFP fluorescence 
data.  For each cell, total fluorescence was calculated by multiplying mean 
fluorescence by area. Because microwells became quite crowded by late time points 
(days 6-7), and cell clumps were very difficult to segment, all cells were counted but 
only a subset of the distinguishable cells were segmented and sampled to obtain 
fluorescence data for the well. Fifty background fluorescence sample cells were taken 
and the mean total fluorescence for CD25 and Bcl11b-YFP plus 3 standard deviations 
was used to set the thresholds for determination of positive vs. negative cells. 
Pseudo time series 
From the single cell FISH data, pseudo-time-series were created by clustering the 
data and ordering the clusters, assuming that the cells measured are in states 
distributed over the whole-time intervals of both stages DN1 and DN2. The data points 
were first classified into clusters with a Gaussian-Mixture algorithm51,  assuming that 
they follow several Gaussian distributions with individual parameters. Moreover, the 
number of data points in each cluster should be similar in order to regard all data with 
the same significance. The mean expression and standard deviation of all data points 
in a cluster were then computed for each gene and used to arrange the clusters in 
time. The cluster order was set by the fact that both Tcf7 and Bcl11b expression levels 
are known to increase during cell commitment52,53. We considered the relative values 
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of gene expression levels with respect to the maximum level at each stage to prohibit 
Tcf7 from dictating the order of the clusters alone, since its absolute expression is 
higher than Bcl11b expression. For each cluster, expression values of Tcf7 and 
Bcl11b were added. Finally, the clusters were ordered such that this sum is increasing 
and placed equidistantly on an arbitrary time axis. 
 
Single Cell Model - Transcription Level 
For the circuit in Fig. 6A we obtained the following set of rate equations from a 
thermodynamic approach42. The equations describe the dynamics of T-cell specific 
genes Tcf7, Gata3 and Runx1 along with gene opposing the T-cell fate PU.1 and X 
function, with concentration levels denoted as: [T], [G], [R], [P] and [X]. The Notch 
signalling activity is denoted as N. 𝜕[𝑅]𝜕𝑡 = 𝑝([𝑅] + 𝑝*𝑁1 + 𝑝([𝑅] + 𝑝*𝑁 − 𝛾/[𝑅] 
𝜕[𝑇]𝜕𝑡 = 𝑝1[𝑇] + 𝑝2𝑁𝑝3 + [𝑃]1 + 𝑝1[𝑇] + 𝑝2𝑁 + 𝑝5[𝑃] − 𝛾6[𝑇] 
𝜕[𝐺]𝜕𝑡 = 𝑝8[𝑇] + 𝑝9𝑁𝑝: + [𝑃]1 + 𝑝8[𝑇] + 𝑝9𝑁 + 𝑝(;[𝑃] − 𝛾<[𝐺] 𝜕[𝑃]𝜕𝑡 = 𝑝(([𝑃]1 + 𝑝(([𝑃] + 𝑝(*[𝑅][𝐺][𝑇] − 𝛾=[𝑃] 𝜕[𝑋]𝜕𝑡 = 11 + 𝑝(1[𝑇] + 𝑝(2[𝐺] − 𝛾?[𝑋] 𝜕𝑁𝜕𝑡 = 𝑝(31 + 𝑁 
We considered that repression of Pu.1 by the T-cell specific factors follows AND logic 
i.e. Runx1, Tcf7 and Gata3 all need to be present for active repression of Pu.1. This 
accounts for the experimentally observed increases in Pu.1 expression upon deletion 
or downregulation of any one of these regulators (see Table 1 for references). We 
modelled the Notch activity such that the N levels increase throughout the 
simulations, however, parameter p15 values were chosen to be very low to assure only 
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a slight increase of the Notch activity, avoiding a jump to infinity. Pu.1 limits the up-
regulation of Tcf7 and Gata3 by Notch signalling. This was modelled by dividing the 
Notch activation term, in the nominator of the rate equations of Tcf7 and Gata3, by a 
linear term including Pu.1 expression level. The rest of interactions in the model follow 
a standard Shea-Ackers formalism implementation. The parameters pi with i=1:14 
except p5, p9, which are part of implementation of Pu.1 impeding the Notch positive 
regulation of Tcf7 and Gata3, correspond to binding affinities, while g parameters 
model the decay rates linked to the half-lives of the respective molecules. The 
parameter values (Table S1) were chosen such as the resulting expression levels 
dynamics for all the genes in the network are within the range levels of genes 
expression observed in the single cell FISH experiments (Fig. S6). The model 
parameters were optimised (Supplementary Material) from the pseudo-time-series 
data using simulated annealing, genetic algorithms and a bound constrained 
optimisation algorithm (L-BFGS-B)54 with the latter performing best.  
Single Cell Model - Epigenetic Level 
We implemented a simplified computational model for Bcl11b regulatory system 
transition from chromatin closed to open state. The epigenetic level model is linked 
to the transcription level model through the fact that the expression of Runx1 and X 
and level of activity of Notch signalling (outputs of transcription level model) serve as 
inputs to the Bcl11b regulatory system model. We consider that Runx1 along with 
Notch signalling activity push towards an open Bcl11b regulatory system state thus 
the probability of achieving this state is direct proportional to Runx1 and Notch levels. 
X activity is considered to help maintain a closed state of the Bcl11b regulatory 
system, dictating the probability of the regulatory region to be closed. We initially put 
forward a very simplified model in which we considered the size of the Bcl11b 
regulatory system to have a finite low number of CpG sites i.e. 20. This was chosen 
to make sure that the simulations were very fast, but that we considered enough CpG 
sites so that the transitions between the opened and closed states are not instant and 
not completely controlled by noise. The amount of existing CpG sites in one of the 
states influences negatively the amount of CpG sites in the other state, because of 
the finite total number of CpG sites. We conducted a stochastic implementation of 
All rights reserved. No reuse allowed without permission. 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/667709doi: bioRxiv preprint first posted online Jun. 11, 2019; 
23 
 
the simplified model for epigenetic state evolution of Bcl11b regulatory region 
governed by the following master equation: 𝜕𝐵ABCD𝜕𝑡 = 𝑝(5𝑅 + 𝑝(8𝑁 − 𝑝(9𝐵EFAGCH 𝜕𝐵EFAGCH𝜕𝑡 = 𝑝(:𝑋 − 𝑝*;𝐵ABCD 
where N denotes Notch signalling activity, R represents the expression level of Runx1 
and X is the X activity level. The model parameter values are shown in Table S2.  
The initial conditions for stochastic simulations of the epigenetic level model consider 
the Bcl11b regulatory system to be in closed state i.e. the number of closed CpG sites 
is greater than the number of sites considered to be open. In some simulations the 
Bcl11b regulatory system becomes open i.e. the number of opened CpG sites 
becomes and remains greater than the number of closed CpG sites during simulation 
time. 
Multi-scale model of proliferation and gene expression 
To analyse the effects of cell proliferation on the population scale gene expression we 
devised a model in which we can track the gene expression and division history of 
each individual cell. The model is an extension of in house developed framework, 
written in C++ and used previously in the context of cell-based simulations55. The 
mechanical interactions between cells are modelled in the same manner as in the 
original implementation. Each cell in the model contains a copy of a gene network 
presented in Single Cell Model (both transcription and epigenetic levels) and evolves 
its gene expression levels independently from other cells by a stochastic Gillespie 
simulation43. Cell cycle length for each cell is also a stochastic variable and chosen 
from a normal distribution. The cell divisions are assumed to be symmetric such that 
the daughter cells inherit the mother cell content, but then evolve independently. 
Since we assume that the presented network describes transition from DN1 to DN2a 
cell state in the multi-cell simulations we turn on the network in its initial state between 
day 1 and day 2 while the start of the simulation at day 0 corresponds to introduction 
of a single DN1 clone to the well. 
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We constructed a unified model of cell proliferation consistent with the data by 
assuming that the cell cycle length is a function of the cell generation. The parameters 
of the cell cycle length normal distributions were chosen independently for each cell 
based on its generation and fitted globally to the CTV data in Table S4. 
In order to take into account the effect of cell division on the amounts of epigenetic 
factors inside a cell, we implemented a Bcl11b regulation region epigenetic model 
where the regulatory system can be open, close or at an intermediate state 
corresponding, in a CpG site methylation model, to the methylated, unmethylated and 
hemi-methylated states (Fig. S8). This type of collaborative model was proposed in44,48 
and used here to simulate the opening and closing of the Bcl11b regulation region 
when cells go under division process.  In the model the CpG sites can be methylated 
(M) -- closed state, hemi-methylated (H) -- intermediate state or unmethylated (U) -- 
open state. Transition rate constants depend on the level of X activity, expression 
level of Runx1 as well as Notch signalling activity. The arrows labelled with a to e 
indicate reactions that require a mediator nearby (e.g. the a arrow defines a transition 
from U to H in the presence of a mediator in state M). 
The collaborative model is described be the following set of equations: 𝜕𝑈𝜕𝑡 = (𝑘*𝑁 + 𝑘1[𝑅])𝐻 − 𝑘([𝑋]𝑈 + g𝐻𝑈 − a𝑈𝑀 𝜕𝐻𝜕𝑡 = 𝑘([𝑋]𝑈 + (𝑘*𝑁 + 𝑘1[𝑅])𝑀 − (𝑘([𝑋] + 𝑘*𝑁 + 𝑘1[𝑅])𝐻 + a𝑈𝑀 + d𝑀𝑈 − g𝐻𝑈− b𝐻𝑀 − e𝐻𝐻 𝜕𝑀𝜕𝑡 = 𝑘([𝑋]𝐻 − (𝑘*𝑁 + 𝑘1[𝑅])𝑀 + b𝐻𝑀 + e𝐻𝐻 − d𝑀𝑈 
The parameter values are shown in Table S5. 
When we simulate division in the multi-scale model, two new Gillespie simulations are 
started. In the absence of X, and in response to Runx1 (R) and Notch signals (N), the 
states of the mother cell Bcl11b regulatory region CpG sites are transferred to the 
daughters following the rule: M -> H, H -> 50% H + 50% U, U -> U48. It should be 
noted that when the collaborative model was used, the Bcl11b regulatory system had 
to be of a size of minimum 500 CpG sites. The results shown in Fig. 8C were obtained 
only if the regulatory region of Bcl11b went through epigenetic events corresponding 
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to demethylation of at least 500 CpG sites. Note that the real Bcl11b gene includes 
multiple methylated CpG islands in the gene body and also possesses extended 
enhancers spread over more than 850 million bp of DNA32,37, so this constraint is quite 
likely to be biologically meaningful. 
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TABLE 1: Gene network components and sources of evidence 
From To Effect Evidence Type References Index 
Notch Runx1 Activate Modest up-
regulation in pro-T 
cells 
21 1 
Notch  Tcf1 Activate Direct binding and 
activation 
16,17 2 
Notch  Gata3 Activate  Developmental 
activation 
requirements and 
protection from 
repression, but no 
direct binding 
evidence  
8,53,56,57 3 
Runx1 Runx1 Activate Auto-regulation seen 
in HSC precursors in 
embryo (’Cbfa2’); 
many binding sites; 
not certain in pro-T  
58 4 
Runx1 PU.1 Repress Direct molecular 
evidence of 
repression through 
interaction sites  
11,15,26,59 5 
PU.1 PU.1 Activate Functionally only in 
myeloid cells, 
promoter activation 
and auto-regulation 
via cell cycle  
6,18,41 6 
PU.1 Tcf1 Repress Functional 
perturbation; possibly 
indirect due to 
paucity of binding  
10,21,23 7 
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PU.1 Gata3 Repress Functional 
perturbation; 
dependent on 
absence of Notch 
signal  
21 8 
Notch Repression of 
Gata3 by PU.1  
Inhibit Functional 
perturbation 
21 9 
PU.1 Ability of 
Notch to 
activate Tcf1  
Inhibit Functional 
perturbation 
10,21 10 
PU.1 Ability of 
Notch to 
activate 
Gata3 
Inhibit Functional 
perturbation 
21 11 
Tcf1 Gata3 Activate Gain and loss of 
function perturbation 
in pro-T cells  
17 12 
Gata3 Tcf1 Activate Genetic perturbation 
and retroviral 
interference  
19,22 13 
Tcf1 X Repress Conjectural Interpretation 
24,39 
14 
Gata3 X Repress Conjectural Interpretation 
22,24,39 
15 
Tcf1 Tcf1 Activate Gain and loss of 
function perturbation 
in pro-T cells  
17 16 
X Bcl11b Repress Epigenetic constraint 
on Bcl11b activation, 
apparently not 
24,39 17 
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relieved until after 
DN1 to DN2 transition  
TABLE 1 PERTURBATION EXPERIMENTS FOR T-CELL COMMITMENT - GENE REGULATORY NETWORK.  
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TABLE 2 Epigenetic model components and source of evidence. 
From To Effect Evidence Type References 
Runx1 Bcl11b Open positively regulates Bcl11b 
expression amplitude at single-cell 
level based on gain and loss-of-
function perturbation; direct DNA 
binding  
24,26,60 
Notch Bcl11b Open accelerates and enhances 
frequency up-regulation from DN2; 
primes for activation in DN1  
53, 24 
X Bcl11b Close conjectural 
based on stage-dependent 
prohibition and inter-allelic 
asynchrony  
24, 39 
TABLE 2. PERTURBATION EXPERIMENTS FOR T-CELL COMMITMENT - EPIGENETIC REGULATION MODEL. 
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FIG. 1 
Multi-scale modelling roadmap. A Schematic of T-cell development. Figure shows 
initial Notch-dependent stages after multipotent precursors immigrate to thymus. The 
most immature Kithigh Early T Precursors (ETP) are referred to here as DN1. At DN3, T-
cell receptor gene rearrangement occurs, and all subsequent development depends 
on T-cell receptor expression and signalling. B Bipartite model for control of onset of 
Bcl11b expression in single cells. B-left deterministic component of model: 
establishing permissiveness for Bcl11b activation. B-right stochastic component of 
model: probabilistic onset of Bcl11b transcription via positive transcriptional 
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regulators and removal of local epigenetic constraint.  Figure shows flow chart of 
research in this paper. The deterministic model parameters are optimized by fitting 
simulation results  to single cell FISH data. X activity levels represent a constraint 
function for activity of the Bcl11b regulatory region in the second-level, epigenetic 
stochastic computational model (green arrows). Stochastic simulations of the 
resulting single cell multi-level model are conducted and statistics of percentage of 
cells opening the Bcl11b regulatory region at each day of experiment are predicted. 
C Experimental measurements of proliferation and developmental kinetics from DN1 
to committed T-cells. The number of cell divisions is measured using Cell Trace Violet, 
as well as the percentage of CD25-positive and Bcl11b-YFP-positive cells, for 
validation of the single cell multiple stochastic simulation predictions (red arrow). D 
The single cell model is subsequently plugged into the multi-cell population dynamic 
model (blue arrow) using parameters trained with empirical proliferation data. 
Predictions from the multi-scale model are finally validated (red arrow) using E live-
cell time-lapse imaging experimental data measuring proliferation and differentiation 
of individual DN1 clones. 
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FIG. 2 
Proliferation and developmental kinetics from multipotent DN1 progenitors to T-
lineage committed cells. A Flow cytometry plots showing early T-cell developmental 
stages (DN1-DN4) and the gating strategies used for purifying progenitor DN1 cells, 
Kithigh and lacking CD25 and Bcl11b-YFP, for in vitro experiments. B-D In vitro analysis 
of proliferation and development from sorted thymic DN1 cells.  DN1 cells were 
purified from thymi of Bcl11b-YFP reporter mice, stained with a proliferation tracking 
dye, Cell Trace Violet (CTV), co-cultured with Notch ligand expressing OP9-DL1 
stromal cells, and harvested for flow cytometric analysis on days 2-5. B Flow plots 
show the upregulation of CD25 followed by Bcl11b-YFP expression from days 2 to 5 
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(left), and the relationships between CD25 (middle) and Bcl11b-YFP (right) expression 
and the numbers of cell cycles each cell has experienced as determined by CTV levels 
(colour coded by cell division as shown; see Fig. S1 for details). C Summary plots of 
the distributions of the numbers of cell divisions for cultured DN1 cells each day as 
measured by CTV. D Summary plots of the percentages of CD25-positive cells (blue) 
and percentage of Bcl11b-YFP-positive cells (red) from each day. The histograms 
show mean and standard deviation of data from two experiments.   
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FIG. 3 
Kinetic analysis of proliferation and differentiation for individual DN1 clones. A Diagram 
of protocol used for imaging DN1 clones. Thymic DN1 cells were purified from mice 
homozygous for mTomato and the nuclear Bcl11b-YFP reporter, added to microwells 
pre-seeded with OP9-DL1 stroma, and cultured with cytokines IL-7 and Flt3L and 
CD25-AlexaFluor647 antibodies (marking progression to DN2).  Individual microwells 
with one DN1 cell were imaged daily from day 0 to 6 or 7. B False-colour merged 
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images of one DN1 clone for days 0 to 5: mTomato (gray), surface CD25 (magenta), 
and nuclear Bcl11b-YFP (cyan). Exposures were adjusted to allow visualization of 
cells in all channels. C Higher magnification merged false-colour images of selected 
cells from two DN1 clones showing the original DN1 cells lacking CD25 and Bcl11b-
YFP expression on day 1 and the expression of CD25 (magenta) and Bcl11b-YFP 
(cyan) over time. D Combined proportions of cells expressing the two differentiation 
markers, CD25 and Bcl11b-YFP, alone or together over time.  n=67 (including 62 T-
lineage clones, 2 non-T clones, 3 non-clonal wells). E Log plots of cell numbers 
counted from daily images of 62 clonal T-lineage wells. Wells with only 1 cell on either 
day 1 or 2 were considered to be clonal. F (Left) Plot showing the timing of expression 
of CD25 and Bcl11b-YFP, scored as the days until >50% of cells in individual clones 
were positive for CD25 (n=62 clones) or Bcl11b-YFP (n=58), and the difference in time 
between the two events for the clones that turned on both markers during the 
experiment (n=58). (Right) Plot of the difference in cell cycles for individual clones 
between 50% of cells turning on CD25 and 50% turning on Bcl11b-YFP (n=58). Each 
symbol represents a single clone. Means and standard deviations are indicated with 
lines. 
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FIG. 4 
Regulatory gene expression measurement by smFISH. A Schematics of smFISH 
hybridizations. Primary probes were hybridized against mRNAs in immobilized DN 
cells in pools, and genes were detected with readout probes in groups of 4 genes, 
imaged and stripped with formamide before the second round of readout 
hybridizations. B Representative microscopy images. Each mRNA transcript was 
represented by a single dot under fluorescent microscopy, and the transcripts of 
each gene were counted (Tcf7, red; Gata3, magenta; Spi1, gray; Runx1, green) and 
assigned to individual cells that were categorized into DN1-DN2-DN3-DN4 by 
antibody stained surface markers Kit (red) and CD25 (encoded by Il2ra, green)). C 
Violin plots of transcript count distributions of Runx1, Gata3, Spi1 (PU.1), Tcf7 and 
Bcl11b in single cells, showing median and quartiles, in developmental stages DN1-
DN3. n = 169.  
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Fig. 5 
Flowchart of experimental and modelling steps emphasising predictions versus 
calibrations. Level 1: Bulk and single cell experiments are used to develop a 
dynamical model with both deterministic and stochastic versions. Level 2: The latter 
are augmented with an epigenetic model for Bcl11b expression. The resulting relative 
production rates of cells expressing Bcl11b are validated against bulk data. Cell Trace 
Violet data are then used to develop a population model for the different stages. Level 
3 This model is subsequently combined with the stochastic model from level 2 into a 
multi-level model that is validated against clonal imaging results. 
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FIG. 6 
Core Circuit along with Pseudo-Time-Series data. A Gene Regulatory Network 
Topology, where each interaction has an index corresponding to the rightmost 
column in Table 1. The arrows indicate positive DNA regulation. The thick red lines 
with short bars represent repression of DNA regulation. The thin red lines with short 
bars depict PU.1 repression of Notch activation of Tcf1 and Gata3 and Notch 
inhibition of Pu.1 repression of Gata3 regulation. The dashed red line with short bar 
represents the function X causing epigenetic repression of Bcl11b. B Pseudo-Time-
series obtained from ordering the clusters resulting from the Gaussian Mixture 
algorithm such as the resulting dynamics of Tcf7 and Bcl11b are similar to 
experimentally observed behaviour. Please note the different scales on the y axis, 
TCF7 having the highest counts therefore a scale to 100. The pseudo times-series 
data is shown as mean and standard deviation of each cluster, each dot depicting the 
mean value of the mRNA count for each cluster obtained from the FISH single 
molecule data 
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FIG. 7  
Single Cell Model Results. A. Gene regulatory network topology for transcriptional 
level of the single cell model where the thick red lines denote repression, the black 
arrows denote DNA regulation and the thin red lines denote inferred interactions from 
functional perturbation experiments. B Schematic representation of the epigenetic 
level model for the Bcl11b regulatory regions where Runx1 and Notch (blue and grey 
arrows) favour open DNA for transcription while X (green arrow) is keeping the Bcl11b 
regulatory regions closed. The green, blue and grey arrows show that X function 
activity levels along with Runx1 expression levels and Notch signalling activity serve 
as inputs for the epigenetic level of the single cell model. C Stochastic simulation 
results obtained from transcriptional level model. Simulation results where the system 
stays in a state controlled by Pu.1 and X are shown in the first time series plot. In the 
second plot, the T-cell factors are switched on while Pu.1 and X are down-regulated. 
D Stochastic simulations obtained from the epigenetic level model, shown in panel B, 
having inputs from the levels of Runx1, Notch and X obtained from stochastic 
simulations of the transcriptional level model. In the first plot, the multi-level single cell 
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model stochastic simulation shows that the Bcl11b regulatory region stays closed 
while in the second plot the regulatory region becomes open. E Distribution (yellow) 
of the percentage of single-cell multi-level model simulations with the outcome of 
Bcl11b regulatory region open (mean and standard deviations for 3 sets of 100 single 
cells model simulations). F Distribution (green) of the percentage of single cell model 
simulations where X activity levels have low values at time points corresponding to 
each day of the experiment (mean and standard deviations for 3 sets of 100 single 
cells model simulations). The two distributions show that the model predicts a clear 
delay between the X loss of activity and Bcl11b regulatory region opening (e.g. at day 
2 almost 50% of cells have lost X while less of 10% are Bcl11b positive). 
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FIG. 8  
A Time snapshots of the evolving model cell culture starting from a single DN1 cell. 
Top left: Green scale shows X function activity impacting the epigenetic behaviour of 
the Bcl11b regulatory regions. Bottom left: Cells with opened/closed regions are 
indicated in gold/black respectively. Top right: Expression of Tcf7, which is predicted 
to be maximal during DN1-DN2a transition. Bottom right: Expression timeline of all 
genes for two selected cells; the first non-switching and the other switching to DN2a 
state. B Multi-scale model distributions of cell generations for each day. C Multi-scale 
model predictions of the mean of proportions of cells showing low X activity (green) 
along with the mean proportion of cells with the Bcl11b regulatory region open 
(yellow) at simulation times corresponding to day 2 to day 5 of CTV and single cell 
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imaging experiments. Also shown are the standard errors from 172 
simulations. D Number of cells from 172 simulations starting with one DN1 cell, 
showing the predictions on variability in proliferation kinetics between clones. E Multi-
scale model predictions showing the proportion of simulations versus required time 
to reach 50% Bcl11b regulatory region open in each run. The number on top of the 
bins show the exact count of individual simulations reaching 50% at each day out of 
172 runs. E Multi-scale model predictions showing the proportion of individual 
simulation runs versus the necessary time to reach 50% Bcl11b positive in each run. 
The numbers on top of the bins show the exact count of individual simulations 
reaching 50% at each day. F Multi-scale model predictions showing the proportion of 
individual simulations versus the time to reach 50% X activity loss among the 
simulated cells in each run. Also shown are the number of individual simulations 
reaching 50% at each day.  
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